Literature DB >> 22033797

Acute dialysis-associated peritonitis in children with D+ hemolytic uremic syndrome.

Marta Adragna1, Alejandro Balestracci, Laura García Chervo, Silvina Steinbrun, Norma Delgado, Liliana Briones.   

Abstract

Acute peritoneal dialysis (PD) is the preferred therapy for renal replacement in children with post-diarrheal hemolytic uremic syndrome (D+ HUS), but peritonitis remains a frequent complication of this procedure. We reviewed data from 149 patients with D+ HUS who had undergone acute PD with the aim of determining the prevalence and risk factors for the development of peritonitis. A total of 36 patients (24.2%) presented peritonitis. The median onset of peritonitis manifestations was 6 (range 2-18) days after the initiation of dialysis treatment, and Gram-positive microorganisms were the predominant bacterial type isolated (15/36 patients). The patients were divided into two groups: with or without peritonitis, respectively. Univariate analysis revealed that a longer duration of the oligoanuric period, more days of dialysis, catheter replacement, stay in the intensive care unit, and hypoalbuminemia were significantly associated to the development of peritonitis. The multivariate analysis, controlled by duration of PD, identified the following independent risk factors for peritonitis: catheter replacement [p = 0.037, odds ratio (OR) 1.33, 95% confidence interval (CI) 1.02-1.73], stay in intensive care unit (p = 0.0001, OR 2.62, 95% CI 1.65-4.19), and hypoalbuminemia (p = 0.0076, OR 1.45, 95% CI 1.10-1.91). Based on these findings, we conclude that the optimization of the aseptic technique during catheter manipulation and early nutritional support are targets for the prevention of peritonitis, especially in critically ill patients.

Entities:  

Mesh:

Year:  2011        PMID: 22033797     DOI: 10.1007/s00467-011-2027-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  32 in total

1.  Haemolytic-uraemic syndrome--the experience in Argentina.

Authors:  H A Repetto
Journal:  Nephrol Dial Transplant       Date:  1999-03       Impact factor: 5.992

2.  Epidemiology and outcomes of peritonitis in children on peritoneal dialysis in Australasia.

Authors:  Esmeralda B Bordador; David W Johnson; Paul Henning; Sean E Kennedy; Stephen P McDonald; John R Burke; Steven J McTaggart
Journal:  Pediatr Nephrol       Date:  2010-09       Impact factor: 3.714

3.  Outcome of gram-positive and gram-negative peritonitis in patients on continuous ambulatory peritoneal dialysis: a single-center experience.

Authors:  Narayan Prasad; Amit Gupta; Raj K Sharma; Kashi N Prasad; Sanjeev Gulati; Ajay P Sharma
Journal:  Perit Dial Int       Date:  2003-12       Impact factor: 1.756

Review 4.  Prevention of peritonitis in children: emerging concepts.

Authors:  Sevcan A Bakkaloglu
Journal:  Perit Dial Int       Date:  2009-02       Impact factor: 1.756

5.  Exit-site care--is it time for a change?

Authors:  B J Hasbargen; D J Rodgers; J A Hasbargen; M J Quinn; M K James
Journal:  Perit Dial Int       Date:  1993       Impact factor: 1.756

Review 6.  Clinical practice. Today's understanding of the haemolytic uraemic syndrome.

Authors:  Johanna Scheiring; Alejandra Rosales; Lothar Bernd Zimmerhackl
Journal:  Eur J Pediatr       Date:  2009-08-26       Impact factor: 3.183

7.  Hypoproteinemia in the hemolytic-uremic syndrome of childhood.

Authors:  V L Serebruany; M J Christenson; J Pescetti; R H McLean
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

8.  Paediatric acute peritoneal dialysis in southern Nigeria.

Authors:  I C Anochie; F U Eke
Journal:  Postgrad Med J       Date:  2006-03       Impact factor: 2.401

Review 9.  Dialysis-associated peritonitis in children.

Authors:  Vimal Chadha; Franz S Schaefer; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2009-02-04       Impact factor: 3.714

Review 10.  Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS).

Authors:  Johanna Scheiring; Sharon P Andreoli; Lothar Bernd Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2008-08-13       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.